Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative

symbol logo$MRK Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.49 down -3.49% YoY • Reported revenue of $18.09B up 4.68% YoY • Merck & Co. raised and narrowed full-year 2026 sales outlook to $66.8B to $67.3B and non-GAAP EPS outlook to $2.77 to $2.82, including one-time SciBrunch charge.
1

Price since post

Full Details

Advertisement|Remove ads.